๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Sulpiride trial in chronic schizophrenia with comparison of two dosage regimens

โœ Scribed by D. M. Lewis; H. R. Bond; S. H. Curry

Book ID
104772430
Publisher
Springer
Year
1983
Tongue
English
Weight
472 KB
Volume
80
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.

โœฆ Synopsis

In a study with both open and double-blind phases, a therapeutic response to sulpiride was first established in 18 chronic schizophrenic inpatients. Following this, two dosage regiments, a morning only dose, and the same daily total dose in two equal fractions at 8 a.m. and 4 p.m., were compared using a balanced design, crossover, placebo controlled study. Clinical effects were evaluated by means of the Brief Psychiatric Rating Scale (BPRS). There was a significant reduction in the mean BPRS score in all phases of the study. There was no significant difference between the mean BPRS scores resulting from the two dosage regimens. The study indicated that the two dosage regimens were equally efficacious.

๐Ÿ“œ SIMILAR VOLUMES

A comparison of two oral dosage regimens
A comparison of two oral dosage regimens of 150 mg trazodone in the treatment of depression in general practice
โœ A. Davey ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› Springer ๐ŸŒ English โš– 482 KB

This was a multicentre, double-blind, randomised, parallel-group study which was performed to assess the tolerance and efficacy of administration of 150 mg trazodone nocte as an initial and maintenance therapy compared with a 50 mg t.d.s. regimen. Particular attention was paid to the incidence of ad

Haemodynamic evaluation of two regimens
Haemodynamic evaluation of two regimens of molsidomine in patients with chronic congestive heart failure
โœ G. Lehmann; G. Reiniger; A. Beyerle; H. Zeitler; W. Rudolph ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› Springer ๐ŸŒ English โš– 589 KB

We investigated the extent and duration of the haemodynamic effects of two regimens of molsidomine, i.e. two tablets of a standard regimen consisting of 4 mg given 6 h apart and one tablet of 16 mg in sustained-release form once daily in 13 patients with chronic congestive heart failure using a plac